China Conditionally Approves $35 Billion M&A between AMD and Xilinx
The Chinese government recently approved Advanced Micro Devices (AMD)'s acquisition of Xilinx Inc., which allows the two companies to complete their deal by the end of the first quarter of 2022. This piece summarizes the ruling of the agency reviewing the deal and the conditions it imposed.
U.S. Trade Rep. Katherine Tai Comments on China Trade Issues
At an event today sponsored by the National Asian Pacific American Bar Association, in response to a question about U.S.-China trade issues, U.S. Trade Representative Katherine Tai offered some comments on U.S. trade policy relating to China and the Phase One trade agreement.
WTO Members Question China's Trade Measures Related to COVID and More at SPS Meeting
At a WTO SPS Committee meeting in November, for which the meeting minutes were just circulated, WTO Members discussed a number of SPS measures imposed by China.
WTO Anti-Dumping Committee Sees Discussion of Trade Remedies By and Against China
At the October 27 meeting of the WTO's Committee on Anti-Dumping Practices, a number of issues related to trade remedies against China and trade remedies taken by China were discussed.
U.S. ITC Issues Report on Foreign Censorship Policies and Practices Affecting U.S. Businesses
The U.S. International Trade Commission (ITC) issued a report last week that "identifies and describes various foreign government censorship policies and practices, including examples that U.S. businesses consider impediments to trade and investment." The report covered a wide range of countries. In this piece, we focus
EU Anti-Dumping Decision on Artificial Sweetener Discusses Role of CCP in Company Management
The European Commission has adopted a definitive anti-dumping duty on imports of acesulfame potassium (an artificial sweetener) originating in the People’s Republic of China following an expiry review of existing duties. The new anti-dumping duty rates ranged from 2.64 to 4.58%. One aspect of the
CTM Weekly Newsletter
This past week's CTM pieces covered WTO disputes involving China at various stages of the dispute settlement process; new Chinese government rules on gene-editing and GMOs, and China's trade and investment policies in 2022; a new U.S. bill targeting China's censorship, new